RESOF TOTAL TABLET 28'S

Resof total tablet has shown efficacy in treating hepatitis C in individuals with advanced liver disease or compensated cirrhosis. However, the response rate may vary, and close monitoring of liver function is important during and after treatment.

Yes, regular blood tests are typically conducted during Resof total tablet treatment to monitor liver function, viral load, and treatment response. These tests help assess the effectiveness of the medication and ensure patient safety.

Resof total tablet can be used in patients with mild to moderate kidney impairment without dose adjustment. However, patients with severe renal impairment or end-stage renal disease may require dose adjustments or alternative treatment options. It is important to discuss your kidney function with your healthcare provider to determine the most appropriate treatment plan.

Resof total tablet is effective and safe in individuals with both hepatitis C and HIV co-infection. However, it is important to coordinate treatment with both infectious disease and HIV specialists to ensure proper management of both conditions.

Weight gain or loss is not commonly reported as a side effect of the Resof total tablet. However, individual responses to medication can vary. If you experience any unexplained or concerning changes in weight during treatment, it is recommended to consult your healthcare provider for further evaluation.

Resof total tablet can be used in patients with a history of liver transplantation who have recurrent hepatitis C. However, individual patient factors and the specific post-transplantation period must be considered. Consultation with a transplant hepatologist or specialist is recommended to determine the most appropriate treatment approach.

While Resof total tablet is generally well-tolerated, like any medication, it can potentially cause side effects. Common side effects include headache, fatigue, nausea, and insomnia. Serious side effects are rare but can include severe allergic reactions, changes in heart rate, and liver problems. It is important to discuss any concerns or potential side effects with your healthcare provider, who can provide further information and guidance based on your specific situation.

Before starting treatment, you should be screened for Hepatitis B (HBV) due to the risk of the virus becoming active again. Your liver function and HBV levels need to be monitored closely during and after treatment, especially if you have or had an HBV infection. Also, tell your doctor about all medications you are currently taking, as RESOF TOTAL TABLET 28'S can interact with other drugs. If you are taking amiodarone, your heart rate will be closely monitored.

Patients with mild to moderate kidney problems can take RESOF TOTAL TABLET 28'S, but those with severe kidney problems or on dialysis may need dose changes or a different treatment. It is effective and safe for people with HIV/HCV co-infection, but treatment should be coordinated with specialists. Patients who have had a liver transplant and have recurring hepatitis C can use RESOF TOTAL TABLET 28'S, but this needs to be discussed with a transplant specialist. If you have a history of mental health issues or are pregnant or breastfeeding, discuss this with your doctor.

RESOF TOTAL TABLET 28'S contains the active ingredients Sofosbuvir and Velpatasvir.

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection.

RESOF TOTAL TABLET 28'S is used to treat chronic (long-lasting) Hepatitis C infection. It works by reducing the amount of Hepatitis C virus in the body, which helps your liver recover.

RESOF TOTAL TABLET 28'S is a highly effective medication that can cure Hepatitis C in many cases, leading to a sustained viral response.